Literature DB >> 10764672

Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey.

E S Ford1, W H Giles.   

Abstract

C-reactive protein may predict the risk of coronary heart disease, but its association with stroke has not been well studied. We used data from the Third National Health and Nutrition Examination Survey, conducted from 1988 to 1994, to examine the association between serum C-reactive protein concentrations and self-reported past history of stroke among 8850 US men and women aged >/=40 years. The unadjusted geometric mean of C-reactive protein concentration was higher among participants with stroke than those without stroke (0. 45+/-0.02 versus 0.32+/-0.01, P<0.001). After adjusting for age, sex, race or ethnicity, education, smoking status, systolic blood pressure, serum cholesterol, high density lipoprotein cholesterol, history of diabetes mellitus, body mass index, and physical activity, the odds ratio for stroke among participants with C-reactive protein concentrations >/=0.55 mg/dL compared with participants with concentrations </=0.21 mg/dL was 1.71 (95% CI 1.11 to 2.64 [odds ratio per mg/dL 1.19, 95% CI 1.05 to 1.34]). These cross-sectional data support findings from other studies suggesting that C-reactive protein concentration may be a risk factor or marker for stroke in the US population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764672     DOI: 10.1161/01.atv.20.4.1052

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  22 in total

Review 1.  The use of high-sensitivity assays for C-reactive protein in clinical practice.

Authors:  Kiran Musunuru; Brian G Kral; Roger S Blumenthal; Valentin Fuster; Catherine Y Campbell; Ty J Gluckman; Richard A Lange; Eric J Topol; James T Willerson; Milind Y Desai; Michael H Davidson; Samia Mora
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08-19

2.  The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.

Authors:  M S V Elkind; J M Luna; C S Coffey; L A McClure; K M Liu; S Spitalnik; M C Paik; A Roldan; C White; R Hart; O Benavente
Journal:  Int J Stroke       Date:  2010-04       Impact factor: 5.266

3.  The vascular effects of infection in Pediatric Stroke (VIPS) Study.

Authors:  Heather J Fullerton; Mitchell S V Elkind; A James Barkovich; Carol Glaser; David Glidden; Nancy K Hills; Carlos Leiva-Salinas; Max Wintermark; Gabrielle A Deveber
Journal:  J Child Neurol       Date:  2011-05-25       Impact factor: 1.987

4.  C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome.

Authors:  K Rajeshwar; Subhash Kaul; Amal Al-Hazzani; M Sai Babu; N Balakrishna; Vandana Sharma; A Jyothy; Anjana Munshi
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

5.  Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.

Authors:  Jessica L Mega; David A Morrow; Christopher P Cannon; Sabina Murphy; Richard Cairns; Paul M Ridker; Eugene Braunwald
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

6.  Gender Differences in C-Reactive Protein and Muscle Strengthening Activity.

Authors:  Michael R Richardson; Tammie M Johnson; Peter T Katzmarzyk; Earl S Ford; William R Boyer; James R Churilla
Journal:  J Phys Act Health       Date:  2015-12

Review 7.  Statin therapy in the elderly: does it make good clinical and economic sense?

Authors:  Moira M B Mungall; Allan Gaw; James Shepherd
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study.

Authors:  Mitchell S V Elkind; Jorge M Luna; Leslie A McClure; Yu Zhang; Christopher S Coffey; Ana Roldan; Oscar H Del Brutto; Edwin Javier Pretell; L Creed Pettigrew; Brett C Meyer; Jorge Tapia; Carole White; Oscar R Benavente
Journal:  Stroke       Date:  2014-02-12       Impact factor: 7.914

9.  Decreased C-reactive protein levels in Alzheimer disease.

Authors:  Sid E O'Bryant; Stephen C Waring; Valerie Hobson; James R Hall; Carol B Moore; Teodoro Bottiglieri; Paul Massman; Ramon Diaz-Arrastia
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-11-20       Impact factor: 2.680

10.  Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy: the northern Manhattan study.

Authors:  Yasuyoshi Takei; Marco R Di Tullio; Shunichi Homma; Bernadette Boden-Albala; Tatjana Rundek; Ralph L Sacco; Grace Berry; Rui Liu; Zhezhen Jin; Kazuo Eguchi; Mitchell S V Elkind
Journal:  Am J Hypertens       Date:  2009-04-23       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.